Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Linda Liau, M.D., Ph.D.
Linda Liau, M.D., Ph.D.

Specialty:

Neurological Surgery

General Information:

Gender:
Female
Language(s):
English

Affiliation(s):

Professor, Department of Surgery, Neurosurgery
Physician, Department of Surgery, Neurosurgery
Member, JCCC Tumor Immunology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Education:

Fellowship:
Neuro-Oncology, UCLA School of Medicine, 1998 - 1998
Residency:
Surgery/Neurosurgery, UCLA School of Medicine, 1992 - 1997
Internship:
Surgery, UCLA School of Medicine, 1991 - 1992
Medical Degree:
M.D., Stanford University School of Medicine, 1991
Degree:
Ph.D., UCLA, 1999

Certification(s):

Board Certification(s):
Neurological Surgery, American Board of Neurological Surgery, 2002

Contact Information:

Phone:
(310) 267-2621
(310) 794-7788 Patient appointments
(310) 825-5111 Neurosurgery and Comprehensive Brain Tumor Program information and referral
Email:
Website:

Practice Information:

Clinical Interest(s):
Brain Tumor

Scientific Interest(s):

Dr. Linda Liau's research efforts are focused on gene therapy and immunotherapy approaches in treating patients with malignant brain tumors.

Selected Cancer-Related Publications:

Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, Lai A, Cloughesy TF, Kornblum HI, Wu H, Fantin VR, Liau LM. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol. 2012 Mar;107(1):197-205. Epub 2011 Oct 21

Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM, Konkankit V. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res. 2011 Mar 15;17(6):1603-15. Epub 2010 Dec 6

Konkankit VV, Kim W, Koya RC, Eskin A, Dam MA, Nelson S, Ribas A, Liau LM, Prins RM. Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway. J Transl Med. 2011 Nov 7;9:192.

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2010 Jun 17;465(7300):966.

Prins RM, Cloughesy TF, Liau LM. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med. 2008 Jul 31;359(5):539-41.